vrbl	or	l95	u95	p	disp	y
industry	0.31895907579446947	0.16923963449677934	0.5638160810181561	1.2020876124171294e-5	industry-sponsored	8
drug	0.5936810690411695	0.378550460018563	0.9262351580802194	0.0165945694709062	drug	7
behav	3.1000820970924523	1.9797537457176588	4.8465876456356884	3.8469184945142406e-7	behavioral	6
device	0.2607460762670085	0.06916038120507693	0.6974598349380426	0.0024061741716962775	device	5
proced	0.6071605649985741	0.07150826428486019	2.3115625652808762	0.7708760126719515	procedure	4
pspec	0.6696018402315523	0.427638117405197	1.044233199511455	0.0660464991400918	specified phase	3
complete	0.8159753801081016	0.5223739079060059	1.2724226822295193	0.3890209932056415	completed	2
has_placebo	0.9778661333238435	0.6181170203457057	1.531448124421211	1	placebo-controlled	1
